Suresh K Alahari

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Oncogene

Proceedings of the National Academy of Sciences of the United States of America

Cancers

PloS one

LSUHSC

Drexel University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

LSUHSC Jul 01 2004

United States

Professor :: Biochemistry

Education History

Drexel University Jan 01 1990 - Apr 01 1994

United States

PHD :: Biotechnology

Publications

Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene (2024)
Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene 43 (11) (2024)
Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene 43 (11) (2024)
Ketakee Mahajan, Ani V Das, Suresh K Alahari, Ramesh Pothuraju, S Asha Nair
MicroRNA-532-3p Modulates Colorectal Cancer Cell Proliferation and Invasion via Suppression of FOXM1. Cancers 16 (17) (2024)
Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene (2024)
Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene 43 (11) (2024)
Courtney B Lagarde, Joachim Kavalakatt, Megan C Benz, Mackenzie L Hawes, Carter A Arbogast, Nicole M Cullen, Emily C McConnell, Caroline Rinderle, Katherine L Hebert, Maninder Khosla, Jorge A Belgodere, Van T Hoang, Bridgette M Collins-Burow, Bruce A Bunnell, Matthew E Burow, Suresh K Alahari
Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene 43 (11) (2024)
Hassan Yousefi, Maninder Khosla, Lothar Lauterboeck, Samuel C Okpechi, David Worthylake, Jone Garai, Jovanny Zabaleta, Jessie Guidry, Mohammad Amin Zarandi, Dorota Wyczechowska, Janarthanan Jayawickramarajah, Qinglin Yang, Joseph Kissil, Suresh K Alahari
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene (2023)
Rareș Drula, Barbara Pardini, Xiao Fu, Mireia Cruz De Los Santos, Ancuta Jurj, Lan Pang, Sherien M El-Daly, Linda Fabris, Erik Knutsen, Mihnea Paul Dragomir, Recep Bayraktar, Yongfeng Li, Meng Chen, Filippo Del Vecchio, Léa Berland, Jessica Y Dae, Daniel Fan, Masayoshi Shimizu, Anh Minh Tran Huynh, Mercedes Barzi, Carlotta Pioppini, Angelica M Gutierrez, Cristina Ivan, Salyna Meas, Carolyn S Hall, Suresh K Alahari, Ioana Berindan Neagoe, Muller Fabbri, Anthony Lucci, Banu Arun, Simone Anfossi, George Adrian Calin
17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (23) (2023)
Hassan Yousefi, Maninder Khosla, Lothar Lauterboeck, Samuel C Okpechi, David Worthylake, Jone Garai, Jovanny Zabaleta, Jessie Guidry, Mohammad Amin Zarandi, Dorota Wyczechowska, Janarthanan Jayawickramarajah, Qinglin Yang, Joseph Kissil, Suresh K Alahari
A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene 41 (47) (2022)
Samuel C Okpechi, Hassan Yousefi, Khoa Nguyen, Thomas Cheng, Nikhilesh V Alahari, Bridgette Collins-Burow, Matthew E Burow, Suresh K Alahari
Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer. Oncogene 41 (8) (2022)
Shengli Dong, Hassan Yousefi, Isabella Van Savage, Samuel C Okpechi, Maryl K Wright, Margarite D Matossian, Bridgette M Collins-Burow, Matthew E Burow, Suresh K Alahari
Ceritinib is a novel triple negative breast cancer therapeutic agent. Molecular cancer 21 (1) (2022)
Hassan Yousefi, Mousa Vatanmakanian, Mojdeh Mahdiannasser, Ladan Mashouri, Nikhilesh V Alahari, Mohammad Rafiee Monjezi, Shahrzad Ilbeigi, Suresh K Alahari
Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene 40 (6) (2021)
Shengli Dong, Bernardo Ruiz-Calderon, Rajamani Rathinam, Steven Eastlack, Mazvita Maziveyi, Suresh K Alahari
Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment. International journal of cancer 146 (9) (2019)
Steven C Eastlack, Shengli Dong, Yin Y Mo, Suresh K Alahari
Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer. PloS one 13 (6) (2018)

Suresh K Alahari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Suresh K Alahari